NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1164684700 MD
Verify on CMS → Shehzad Topiwala, MD
Endocrinology, Diabetes & Metabolism Physician in Stockbridge, Georgia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
6K
Medicare Part D claims · 655 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
43%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$4.1K
127 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Shehzad Topiwala, MD carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 5,644 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 6K
- Part D claims, 2024
- 43%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Shehzad Topiwala, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1164684700), first enumerated 06/25/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 5,644 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$4.1K in reported industry payments (127 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1164684700 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1164684700
- ENUM-MID 2008
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-NEUTRAL 75/100
- RX-MID 5,644
- BOOK-THIN 210 in Georgia
- PHOTO-ENUM Manav Nayyar · 2008
Shehzad Topiwala, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
5,644 ≥ 94th percentile 94% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Shehzad Topiwala, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Shehzad Topiwala, MD?
CMS neutral score, not measuredPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
5,644 106% vs specialty avg
MIPS final score
75/100
Specialty distribution in Georgia
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Georgia providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1164684700 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/25/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Group practice
Hospital and facility affiliations
Facilities where Shehzad Topiwala, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Institute OF Endocrinology Diabetes Health And Hormones
Stockbridge, GA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Shehzad Topiwala, MD. Source: openpaymentsdata.cms.gov.
Total received
$4.1K
Largest payer
Lilly USA, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Shehzad Topiwala, MD - brand share 48.0%
Endocrinology, Diabetes & Metabolism Physician average
48% brand-name claims vs 43% generic, on 5,644 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
5,644
Total Claims
$2.4M
Total Drug Cost
655
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 12,561.933
- Total Day Supply
- 370,670
- Brand vs Generic
- 48% brand / 43% generic
- Brand Drug Cost
- $2.0M
- Generic Drug Cost
- $44K
Patient Demographics
- Average Patient Age
- 71.6 years
- Avg HCC Risk Score
- 1.65
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 95, 65-74: 313, 75-84: 202, 85+: 45
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Shehzad Topiwala, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Levothyroxine Sodium
Levothyroxine Sodium
516 claims
- Ozempic
Ozempic
425 claims
- Mounjaro
Mounjaro
258 claims
- Atorvastatin Calcium
Atorvastatin Calcium
244 claims
- Metformin Hcl
Metformin Hcl
244 claims
- Omnipod 5 Dexg7g6 …
Omnipod 5 Dexg7g6 Pods (Gen 5)
231 claims
- Amlodipine Besylate
Amlodipine Besylate
220 claims
- Synthroid 168
Synthroid
168 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 516 |
| Ozempic Semaglutide | 425 |
| Mounjaro Tirzepatide | 258 |
| Atorvastatin Calcium | 244 |
| Metformin Hcl | 244 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 231 |
| Amlodipine Besylate | 220 |
| Synthroid Levothyroxine Sodium | 168 |
| Jardiance Empagliflozin | 162 |
| Gvoke Hypopen 2-Pack Glucagon | 155 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in GA →
All providers in Georgia →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Shehzad Topiwala, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Shehzad Topiwala, MD's 5,644 claims are above the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Topiwala, both outside Georgia so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Georgia
Other clinicians with the same primary specialty enrolled in Georgia, drawn from the same CMS NPPES roster as Topiwala.
One of 210 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Georgia, 5 are shown here.
Dr. Sayed Aamir
M.D.
Snellville, GA
Dr. Saira Adeel
M.D.
Austell, GA
Dr. Bilal Ahmad
MD
Jonesboro, GA
Dr. Anota Akofu
M.D.
Carrollton, GA
Dr. Saif Al Borgan
MD
Valdosta, GA
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Shehzad Topiwala, MD's specialty? ▼
Shehzad Topiwala, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Stockbridge, Georgia. Credentials: MD.
How much does Shehzad Topiwala, MD prescribe under Medicare Part D? ▼
In 2024, Shehzad Topiwala, MD wrote 5,644 Medicare Part D claims totaling $2.4M in drug costs for 655 beneficiaries.
What is Shehzad Topiwala, MD's Medicare quality score? ▼
Shehzad Topiwala, MD has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Shehzad Topiwala, MD located? ▼
Shehzad Topiwala, MD is located at 226 WILLIS DR, Stockbridge, GA, 30281. Phone: (770) 389-0200.
What is Shehzad Topiwala, MD's NPI number? ▼
Shehzad Topiwala, MD's National Provider Identifier (NPI) is 1164684700, issued on 06/25/2008.
Does Shehzad Topiwala, MD prescribe more brand-name or generic drugs? ▼
Shehzad Topiwala, MD's prescribing is 48% brand-name and 43% generic drugs by claim count, with $2.0M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Shehzad Topiwala, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Shehzad Topiwala, MD's most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Mounjaro. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Shehzad Topiwala, MD accept Medicare? ▼
Shehzad Topiwala, MD appears in CMS Medicare data with 5,644 Part D claims and 655 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Shehzad Topiwala, MD's credentials? ▼
Shehzad Topiwala, MD's NPI is 1164684700 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.